NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,084 filers reported holding NOVARTIS A G in Q4 2018. The put-call ratio across all filers is 0.74 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $24,650 | +0.9% | 242 | 0.0% | 0.01% | +10.0% |
| Q2 2023 | $24,420 | +9.7% | 242 | 0.0% | 0.01% | +11.1% |
| Q1 2023 | $22,264 | +1.4% | 242 | 0.0% | 0.01% | 0.0% |
| Q4 2022 | $21,954 | -95.0% | 242 | -94.8% | 0.01% | -95.7% |
| Q4 2020 | $443,000 | +14.5% | 4,693 | +5.5% | 0.21% | -1.4% |
| Q3 2020 | $387,000 | -1.5% | 4,449 | -1.1% | 0.21% | -19.9% |
| Q2 2020 | $393,000 | +5.6% | 4,500 | -0.2% | 0.27% | -12.2% |
| Q1 2020 | $372,000 | -13.1% | 4,507 | -0.2% | 0.30% | +8.2% |
| Q4 2019 | $428,000 | +8.9% | 4,518 | 0.0% | 0.28% | +2.2% |
| Q3 2019 | $393,000 | -2.5% | 4,518 | +2.3% | 0.28% | 0.0% |
| Q2 2019 | $403,000 | +23.2% | 4,415 | +30.0% | 0.28% | +33.5% |
| Q1 2019 | $327,000 | +29.8% | 3,397 | +15.6% | 0.21% | +12.0% |
| Q4 2018 | $252,000 | +23.5% | 2,939 | +20.4% | 0.18% | +76.9% |
| Q2 2017 | $204,000 | – | 2,441 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MANAGED ASSET PORTFOLIOS, LLC | 332,962 | $27,452,000 | 7.32% |
| Mawer Investment Management Ltd. | 7,721,327 | $636,623,000 | 5.86% |
| Martin Investment Management, LLC | 133,246 | $10,986,000 | 5.56% |
| SCHARF INVESTMENTS, LLC | 1,330,175 | $109,673,000 | 5.48% |
| Hansberger Growth Investors, LP | 46,663 | $3,847,000 | 5.19% |
| Bain Capital Public Equity Management II, LLC | 440,233 | $36,297,000 | 4.25% |
| First Fiduciary Investment Counsel, Inc. | 187,633 | $15,470,000 | 4.10% |
| GARLAND CAPITAL MANAGEMENT INC | 53,555 | $4,416,000 | 4.02% |
| Lowell Blake & Associates Inc. | 37,219 | $3,069,000 | 3.94% |
| PRENTISS SMITH & CO INC | 68,027 | $5,609,000 | 3.89% |